M&T Bank
MRSN

M&T Bank’s Mersana Therapeutics MRSN Stock Holding History

M&T Bank’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,137
Closed -$115K – 1642
2019
Q2 		$115K Sell
1,137
-407
-26% -$47.9K ﹤0.01% 1484
2019
Q1 		$203K Buy
+1,544
New +$194K ﹤0.01% 1409

Other funds holding MRSN

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

M&T Bank's MRSN Position: Q3 2019 in Review

M&T Bank sold out of Mersana Therapeutics (MRSN) in Q3 2019, closing a stake of 1,137 shares — an estimated $115K sold.

M&T Bank first reported a position in MRSN in Q1 2019 and held it in 2 quarters. The position peaked at $203K in Q1 2019. 76 funds tracked by Wall St. Rank hold MRSN as of Q3 2019.

  • M&T Bank reported no remaining Mersana Therapeutics position as of Q3 2019 after selling out during the quarter.
  • M&T Bank sold 1,137 Mersana Therapeutics shares in Q3 2019, an estimated $115K.
  • M&T Bank first reported a position in Mersana Therapeutics in Q1 2019 and held it in 2 quarters.
  • M&T Bank's Mersana Therapeutics position peaked at $203K in Q1 2019.
  • 76 funds tracked by Wall St. Rank held Mersana Therapeutics as of Q3 2019.

Based on M&T Bank's 13F filing for Q3 2019, filed 12 Nov 2019.